Rachida Bouamar

Rachida Bouamar is a researcher at Erasmus MC, affiliated with the Faculty of Medicine in the Department of Pharmacy. Her work focuses on clinical pharmacology and transplantation, particularly in optimizing immunosuppressive therapy for transplant recipients.

Research Interests: Her primary research areas include pharmacokinetics, drug metabolism (especially involving Cytochrome P450 3A5), therapeutic drug monitoring, and outcomes in kidney and heart transplantation. She investigates the impact of immunosuppressants like tacrolimus and everolimus, including variability in drug exposure and strategies for glucocorticoid withdrawal.

Publication Trends: Her recent publications center on randomized controlled trials and clinical studies in transplant pharmacology, emphasizing personalized dosing, intrapatient variability, and minimizing adverse effects. The work spans oncology-related chemotherapy protocols to immunosuppression optimization.

Scientific Contributions:

• Active contributor to high-impact clinical trials in transplant medicine.
• Research cited in patents and widely read on platforms like Mendeley.
• Focus on evidence-based adjustments in immunosuppressive regimens.

Advising and Grants: While no direct students are listed, her involvement in multi-center trials suggests collaboration with research teams and trainees. She has contributed to doctoral research and large-scale clinical protocols, indicating mentorship and grant-supported work, though specific grants are not detailed in the text.

Labs and Teams: Works within a multidisciplinary team at Erasmus MC focused on transplant pharmacology and personalized medicine, collaborating with clinicians and researchers in nephrology, cardiology, and oncology.